Table 2.
Fully adjusted model | Reduced model | |||
Variable | HR (95% CI) | P value | HR (95% CI) | P value |
Group (Enterosgel) | 1.560 (0.881 to 2.764) | 0.127 | 1.737 (1.055 to 2.859) | 0.030 |
Age | 1.016 (0.993 to 1.040) | 0.163 | ||
Gender (female) | 0.756 (0.429 to 1.331) | 0.332 | ||
Site (10 sites)* | 0.129 | |||
Duration of diarrhoea† | 1.001 (0.999 to 1.003) | 0.352 | ||
Use of medications at baseline (No) | 2.253 (1.036 to 4.897) | 0.040 | 1.797 (0.942 to 3.429) | 0.075 |
Nausea at baseline (No) | 0.598 (0.322 to 1.109) | 0.103 | ||
Vomiting at baseline (No) | 0.673 (0.351 to 1.291) | 0.234 | ||
Fever at baseline (No) | 1.887 (0.968 to 3.68) | 0.062 | ||
Abdominal pain at baseline (No) | 2.535 (1.135 to 5.661) | 0.023 | 1.799 (0.999 to 3.242) | 0.050 |
*Individual site data not shown.
†Duration of diarrhoea symptoms prior to randomisation.